The potential move of cannabis from Schedule I to Schedule III would mark one of the most significant policy shifts in U.S. cannabis history since the Nixon administration created the Controlled Substances Act (CSA). This panel of industry insiders and policy experts will dissect rescheduling and its impacts for operators, investors, researchers, and regulators. The discussion will explore potential timelines, regulatory implications, and remaining uncertainties.